153 related articles for article (PubMed ID: 23946113)
1. Aerobic iron-based cross-dehydrogenative coupling enables efficient diversity-oriented synthesis of coumestrol-based selective estrogen receptor modulators.
Kshirsagar UA; Parnes R; Goldshtein H; Ofir R; Zarivach R; Pappo D
Chemistry; 2013 Sep; 19(40):13575-83. PubMed ID: 23946113
[TBL] [Abstract][Full Text] [Related]
2. Molecular identification of potential selective estrogen receptor modulator (SERM) like properties of phytoestrogens in the human breast cancer cell line MCF-7.
Diel P; Olff S; Schmidt S; Michna H
Planta Med; 2001 Aug; 67(6):510-4. PubMed ID: 11509969
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structure-activity relationships and antagonistic effects in human MCF-7 breast cancer cells of flexible estrogen receptor modulators.
Lloyd DG; Smith HM; O'Sullivan T; Zisterer DM; Meegan MJ
Med Chem; 2005 Jul; 1(4):335-53. PubMed ID: 16789891
[TBL] [Abstract][Full Text] [Related]
4. Effects of the environmental estrogens bisphenol A, o,p'-DDT, p-tert-octylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensitive molecular parameters in the human breast cancer cell line MCF-7.
Diel P; Olff S; Schmidt S; Michna H
J Steroid Biochem Mol Biol; 2002 Jan; 80(1):61-70. PubMed ID: 11867264
[TBL] [Abstract][Full Text] [Related]
5. Benzothiepin-derived molecular scaffolds for estrogen receptor modulators: synthesis and antagonistic effects in breast cancer cells.
Meegan MJ; Barrett I; Zimmermann J; Knox AJ; Zisterer DM; Lloyd DG
J Enzyme Inhib Med Chem; 2007 Oct; 22(5):655-66. PubMed ID: 18035834
[TBL] [Abstract][Full Text] [Related]
6. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions.
Jordan VC
J Med Chem; 2003 Mar; 46(6):883-908. PubMed ID: 12620065
[No Abstract] [Full Text] [Related]
7. Xenoestrogen action in breast cancer: impact on ER-dependent transcription and mitogenesis.
Hess-Wilson JK; Boldison J; Weaver KE; Knudsen KE
Breast Cancer Res Treat; 2006 Apr; 96(3):279-92. PubMed ID: 16328721
[TBL] [Abstract][Full Text] [Related]
8. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents.
Jordan VC
J Med Chem; 2003 Mar; 46(7):1081-111. PubMed ID: 12646017
[No Abstract] [Full Text] [Related]
9. Synthesis, antiproliferative and pro-apoptotic activity of 2-phenylindoles.
Kelly PM; Bright SA; Fayne D; Pollock JK; Zisterer DM; Williams DC; Meegan MJ
Bioorg Med Chem; 2016 Sep; 24(18):4075-4099. PubMed ID: 27407030
[TBL] [Abstract][Full Text] [Related]
10. Advances in the science of estrogen receptor modulation.
Meegan MJ; Lloyd DG
Curr Med Chem; 2003 Feb; 10(3):181-210. PubMed ID: 12570707
[TBL] [Abstract][Full Text] [Related]
11. The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer.
McDonnell DP; Wardell SE
Curr Opin Pharmacol; 2010 Dec; 10(6):620-8. PubMed ID: 20926342
[TBL] [Abstract][Full Text] [Related]
12. Development of the β-lactam type molecular scaffold for selective estrogen receptor α modulator action: synthesis and cytotoxic effects in MCF-7 breast cancer cells.
Carr M; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
J Enzyme Inhib Med Chem; 2016; 31(sup3):117-130. PubMed ID: 27476825
[TBL] [Abstract][Full Text] [Related]
13. Benzoxepin-derived estrogen receptor modulators: a novel molecular scaffold for the estrogen receptor.
Lloyd DG; Hughes RB; Zisterer DM; Williams DC; Fattorusso C; Catalanotti B; Campiani G; Meegan MJ
J Med Chem; 2004 Nov; 47(23):5612-5. PubMed ID: 15509159
[TBL] [Abstract][Full Text] [Related]
14. Rational approaches of drug design for the development of selective estrogen receptor modulators (SERMs), implicated in breast cancer.
Makar S; Saha T; Swetha R; Gutti G; Kumar A; Singh SK
Bioorg Chem; 2020 Jan; 94():103380. PubMed ID: 31757413
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells.
Matsumura A; Ghosh A; Pope GS; Darbre PD
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):431-43. PubMed ID: 15876408
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of selective estrogen receptor modulator activity in human breast cancer cells: identification of novel nuclear cofactors of antiestrogen-ERα complexes by interaction proteomics.
Cirillo F; Nassa G; Tarallo R; Stellato C; De Filippo MR; Ambrosino C; Baumann M; Nyman TA; Weisz A
J Proteome Res; 2013 Jan; 12(1):421-31. PubMed ID: 23170835
[TBL] [Abstract][Full Text] [Related]
18. Estrogen Receptor α (ERα)-targeting Compounds and Derivatives: Recent Advances in Structural Modification and Bioactivity.
Guo WY; Zeng SM; Deora GS; Li QS; Ruan BF
Curr Top Med Chem; 2019; 19(15):1318-1337. PubMed ID: 31215379
[TBL] [Abstract][Full Text] [Related]
19. Flexible estrogen receptor modulators: synthesis, biochemistry and molecular modeling studies for 3-benzyl-4,6-diarylhex-3-ene and 3,4,6-triarylhex-3-ene derivatives.
Smith HM; Knox AJ; Zisterer DM; Lloyd DG; Meegan MJ
Med Chem; 2007 Mar; 3(2):135-55. PubMed ID: 17348852
[TBL] [Abstract][Full Text] [Related]
20. 3, 9-di-O-substituted coumestrols incorporating basic amine side chains act as novel apoptosis inducers with improved pharmacological selectivity.
Luo G; Tang Z; Li X; Hou Q; Chen Y; Lao K; Xiang H
Bioorg Chem; 2019 Apr; 85():140-151. PubMed ID: 30612080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
